• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough?经尿道膀胱切除术与根治性膀胱切除术:组织学一致性。我们做得够好吗?
Turk J Urol. 2020 Sep;46(5):354-359. doi: 10.5152/tud.2020.20121. Epub 2020 Jun 1.
2
Accuracy of Transurethral Resection of the Bladder in Detecting Variant Histology of Bladder Cancer Compared with Radical Cystectomy.经尿道膀胱肿瘤切除术与根治性膀胱切除术检测膀胱癌变异组织学的准确性比较。
Eur Urol Focus. 2022 Mar;8(2):457-464. doi: 10.1016/j.euf.2021.04.005. Epub 2021 Apr 16.
3
Variant histologies in bladder cancer: Does the centre have an impact in detection accuracy?膀胱癌的组织学变异:中心机构对检测准确性有影响吗?
Urol Oncol. 2022 Jun;40(6):273.e11-273.e20. doi: 10.1016/j.urolonc.2022.01.008. Epub 2022 Feb 23.
4
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy.根治性膀胱切除术治疗的尿路上皮膀胱癌中变异组织学的预后影响
BJU Int. 2023 Aug;132(2):170-180. doi: 10.1111/bju.15984. Epub 2023 Feb 20.
5
Accuracy and prognostic value of variant histology and lymphovascular invasion at transurethral resection of bladder.经尿道膀胱肿瘤切除术时肿瘤异型性和脉管侵犯的准确性和预后价值
World J Urol. 2018 Feb;36(2):231-240. doi: 10.1007/s00345-017-2116-3. Epub 2017 Nov 11.
6
Role of Inter-Observer Variability and Quantification of Muscularis Propria in the Pathological Staging of Bladder Cancer.膀胱肿瘤病理分期中观察者间差异及固有肌层定量的作用
Clin Genitourin Cancer. 2016 Aug;14(4):e307-12. doi: 10.1016/j.clgc.2016.01.002. Epub 2016 Jan 22.
7
Overview of histologic variants of urothelial carcinoma: current trends and narrative review on treatment outcomes.尿路上皮癌组织学变体概述:当前趋势及治疗结果的叙述性综述
Transl Androl Urol. 2022 Jun;11(6):877-901. doi: 10.21037/tau-22-43.
8
Implications for diagnosis and treatment strategies in non-muscle invasive bladder cancer with variant histology: a systematic review.具有变异组织学特征的非肌肉浸润性膀胱癌的诊断和治疗策略的影响:系统评价。
Minerva Urol Nephrol. 2023 Jun;75(3):278-288. doi: 10.23736/S2724-6051.23.05091-7. Epub 2023 Mar 22.
9
Grading and staging of bladder carcinoma in transurethral resection specimens. Correlation with 105 matched cystectomy specimens.经尿道切除标本中膀胱癌的分级和分期。与105例匹配的膀胱切除标本的相关性。
Am J Clin Pathol. 2000 Feb;113(2):275-9. doi: 10.1309/94B6-8VFB-MN9J-1NF5.
10
Concordance of PD-L1 expression in matched urothelial bladder cancer specimens.PD-L1 表达在配对的尿路上皮膀胱癌标本中的一致性。
Histopathology. 2018 Dec;73(6):983-989. doi: 10.1111/his.13710. Epub 2018 Sep 25.

引用本文的文献

1
Validation of clinical T stages and of prognostic negative markers in patients with muscle invasive bladder cancer: data in the Swedish National Bladder Cancer Registry data from a detailed research database.肌肉浸润性膀胱癌患者临床T分期及预后阴性标志物的验证:瑞典国家膀胱癌登记处的数据——来自详细研究数据库的数据
Transl Androl Urol. 2024 Dec 31;13(12):2757-2770. doi: 10.21037/tau-24-454. Epub 2024 Dec 28.
2
Transurethral resection of bladder tumor-based bladder preservation therapy for refractory high risk non-muscle invasive bladder cancer: Current landscape and future directions.基于经尿道膀胱肿瘤切除术的难治性高危非肌层浸润性膀胱癌膀胱保留治疗:现状与未来方向
Front Surg. 2023 Apr 12;10:1143219. doi: 10.3389/fsurg.2023.1143219. eCollection 2023.
3
Updated pathology reporting standards for bladder cancer: biopsies, transurethral resections and radical cystectomies.膀胱癌更新的病理学报告标准:活检、经尿道切除术和根治性膀胱切除术。
World J Urol. 2022 Apr;40(4):915-927. doi: 10.1007/s00345-021-03831-1. Epub 2021 Sep 23.

本文引用的文献

1
Is transurethral resection alone enough for the diagnosis of histological variants? A single-center study.单纯经尿道切除术是否足以诊断组织学变异型?一项单中心研究。
Urol Oncol. 2017 Aug;35(8):528.e1-528.e5. doi: 10.1016/j.urolonc.2017.03.024. Epub 2017 Apr 19.
2
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy.肌层浸润性膀胱癌分子亚型对新辅助化疗后反应和生存预测的影响。
Eur Urol. 2017 Oct;72(4):544-554. doi: 10.1016/j.eururo.2017.03.030. Epub 2017 Apr 5.
3
Validation of Preoperative Risk Grouping of the Selection of Patients Most Likely to Benefit From Neoadjuvant Chemotherapy Before Radical Cystectomy.根治性膀胱切除术前行新辅助化疗最可能获益患者选择的术前风险分组验证
Clin Genitourin Cancer. 2017 Apr;15(2):e267-e273. doi: 10.1016/j.clgc.2016.07.014. Epub 2016 Jul 22.
4
Sensitivity of initial biopsy or transurethral resection of bladder tumor(s) for detecting histological variants on radical cystectomy.初始活检或膀胱肿瘤经尿道切除术在检测根治性膀胱切除术中组织学变异方面的敏感性。
BMC Urol. 2015 May 30;15:46. doi: 10.1186/s12894-015-0037-2.
5
Does the extent of variant histology affect oncological outcomes in patients with urothelial carcinoma of the bladder treated with radical cystectomy?在接受根治性膀胱切除术治疗的膀胱尿路上皮癌患者中,组织学变异程度是否会影响肿瘤学结局?
Urol Oncol. 2015 Jan;33(1):21.e1-21.e9. doi: 10.1016/j.urolonc.2014.10.013. Epub 2014 Nov 24.
6
Clinical outcomes of cT1 micropapillary bladder cancer.cT1期微乳头型膀胱癌的临床结局
J Urol. 2015 Apr;193(4):1129-34. doi: 10.1016/j.juro.2014.09.092. Epub 2014 Sep 22.
7
Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.鉴定具有不同一线化疗敏感性的浸润性膀胱癌的基底和腔面亚型。
Cancer Cell. 2014 Feb 10;25(2):152-65. doi: 10.1016/j.ccr.2014.01.009.
8
The sensitivity of initial transurethral resection or biopsy of bladder tumor(s) for detecting bladder cancer variants on radical cystectomy.经尿道膀胱肿瘤初始切除术或活检诊断膀胱癌变异在根治性膀胱切除术时的敏感性。
J Urol. 2013 Apr;189(4):1263-7. doi: 10.1016/j.juro.2012.10.054. Epub 2012 Oct 17.
9
Variant (divergent) histologic differentiation in urothelial carcinoma is under-recognized in community practice: impact of mandatory central pathology review at a large referral hospital.在社区实践中,尿路上皮癌的变异(分化)组织学分化认识不足:在大型转诊医院进行强制性中心病理检查的影响。
Urol Oncol. 2013 Nov;31(8):1650-5. doi: 10.1016/j.urolonc.2012.04.009. Epub 2012 May 17.
10
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy.根治性膀胱切除术治疗的纯鳞状细胞癌和具有鳞状分化的尿路上皮癌患者的比较结果。
J Urol. 2012 Jan;187(1):74-9. doi: 10.1016/j.juro.2011.09.056. Epub 2011 Nov 16.

经尿道膀胱切除术与根治性膀胱切除术:组织学一致性。我们做得够好吗?

Transurethral resection of bladder and radical cystectomy: Concordance of histology. Are we good enough?

作者信息

Ngo Carine, Cussenot Olivier, Compérat Eva

机构信息

Department of Pathology, Tenon Hospital, APHP, Sorbonne University, Paris, France.

Department of Urology, Tenon Hospital, APHP, Sorbonne University, Paris, France.

出版信息

Turk J Urol. 2020 Sep;46(5):354-359. doi: 10.5152/tud.2020.20121. Epub 2020 Jun 1.

DOI:10.5152/tud.2020.20121
PMID:32497002
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7483458/
Abstract

OBJECTIVE

Urothelial carcinoma (UC) is heterogeneous, and variant histologies (VH) are more frequent than initially reported. Reporting VH is recommended by several guidelines because of prognostic and therapeutic implications. We evaluated the concordance of VH between the first transurethral resections of the bladder (TURBs) and the following radical cystectomy (RC). This paper is the first to compare VH with a central pathology review between TURB and RC.

MATERIAL AND METHODS

In this retrospective study, we only included those patients who underwent TURB with VH and then RC between 01/2010 and 12/2013 at our institution. The presence of VH in both TURB and RC was assessed and compared according to the 2016 World Health Organization (WHO) classification by a central pathology review.

RESULTS

Among 110 patients who had the initial TURB/RC, 54 (49.1%) were diagnosed with VH, 48 (43%) had a single pattern, and six had (5%) multiple histological patterns. Squamous differentiation was the most common single VH (31%). Twenty patients with UC (18%) showed discordance between TURB and RC, especially in micropapillary versus nested (n=3) cases. Concordant histology between TURB/RC was seen in 82% of the cases.

CONCLUSION

Discrepancies can be seen between TURB and RC when reporting VH, which can be problematic for selection of therapy and management. TURB alone might be insufficient to evaluate the presence of VH, especially in VH with heavy therapeutic implications, such as micropapillary carcinomas. Nevertheless, concordance with a central review by an experienced uropathologist when applying the WHO 2016 classification is 82%.

摘要

目的

尿路上皮癌(UC)具有异质性,变异组织学类型(VH)比最初报道的更为常见。由于其对预后和治疗具有重要意义,多项指南建议报告VH。我们评估了首次经尿道膀胱肿瘤切除术(TURB)与后续根治性膀胱切除术(RC)之间VH的一致性。本文首次比较了TURB和RC之间VH的中央病理审查结果。

材料与方法

在这项回顾性研究中,我们仅纳入了2010年1月至2013年12月期间在我们机构接受TURB且伴有VH并随后接受RC的患者。根据2016年世界卫生组织(WHO)分类,通过中央病理审查评估并比较TURB和RC中VH的存在情况。

结果

在110例接受初次TURB/RC的患者中,54例(49.1%)被诊断为VH,48例(43%)为单一模式,6例(5%)为多种组织学模式。鳞状分化是最常见的单一VH(31%)。20例UC患者(18%)的TURB和RC之间存在不一致,特别是在微乳头型与巢状型(n = 3)病例中。82%的病例中TURB/RC的组织学一致。

结论

在报告VH时,TURB和RC之间可能存在差异,这可能会给治疗选择和管理带来问题。仅TURB可能不足以评估VH的存在,特别是对于具有重大治疗意义的VH,如微乳头癌。然而,在应用WHO 2016分类时,与经验丰富的泌尿病理学家进行中央审查的一致性为82%。